Policies in several states have limited provider rates and levels of reimbursement, as well as constrained operating flexibility, according to Fitch Ratings.
State healthcare cost caps could further pressure hospital operating margins: report Read More »
Cunningham is joining Illumina from Exact Sciences to end the six-month search for a permanent leader.
Illumina names Everett Cunningham as chief commercial officer Read More »
MAIA Biotechnology, Inc. today announced new efficacy data from its Phase 2 THIO-101 clinical trial evaluating THIO sequenced with the immune checkpoint inhibitor (CPI) cemiplimab (Libtayo®) in patients with advanced non-small cell lung cancer (NSCLC) who failed 2 or more standard-of-care therapy regimens.
CARsgen Therapeutics Holdings Limited tumors, announces that the final follow-up results of the investigator-initiated trial CT041-CG4006 (NCT03874897) of satricabtagene autoleucel (“satri-cel”, CT041) (an autologous CAR T-cell product candidate against Claudin18.2) have been published in Nature Medicine on June 3, 2024.
CARsgen Presents Updated Results on Satri-cel in Nature Medicine and at 2024 ASCO Read More »
¿Tienes curiosidad por saber cómo lograr un mejor equilibrio entre tu vida laboral y personal? No busques más que el HONOR 200 Pro. Este innovador teléfono inteligente ofrece una gama de funciones diseñadas para mejorar la productividad, fomentar el bienestar y rea …
Cómo el HONOR 200 Pro fomenta el equilibrio entre la vida personal y laboral Read More »
On 31 May 2024, the magazine Corporate Governance Asia presented the 14th Asian Excellence Award.
Fosun International Garners Four Awards from Corporate Governance Asia Read More »
At Bio International Convention 2024, which is taking place here in San Diego during June 3-6, Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, has announced an immunocytokine with modified IL-10M fused to anti-PD-1 antibody, codenamed FP008.
Fapon Biopharma Announces a Safer Immunotherapy for Cancers Read More »
LadRx Corporation, a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, is pleased to announce that the Company and NantCell, Inc., together with NantCell’s parent company ImmunityBio, Inc., have agreed to a mutual termination of the license of aldoxorubicin entered into in 2017.
LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License Read More »
Photocure ASA, the Bladder Cancer Company, announces that it has commenced activities to support a new initiative enabling U.S. Hospitals and Clinics to offer blue light cystoscopy using a mobile capital equipment model.
Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. Read More »
La acupuntura, una práctica milenaria de la medicina tradicional china, ha sido objeto de debate en la comunidad científica durante décadas. Mientras que algunos la ven como una técnica eficaz para tratar diversas dolencias, otros cuestionan su validez desde un punto de v …
¿Sirve para algo la acupuntura? Una revisión científica de su eficacia Read More »
